Davidson SM - Search Results

1

IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action.

Lecour S, Andreadou I, Bøtker HE, Davidson SM, Heusch G, Ruiz-Meana M, Schulz R, Zuurbier CJ, Ferdinandy P, Hausenloy DJ; on behalf of the European Union-CARDIOPROTECTION COST ACTION CA16225. Lecour S, et al. Among authors: davidson sm. Basic Res Cardiol. 2021 Sep 13;116(1):52. doi: 10.1007/s00395-021-00893-5. Basic Res Cardiol. 2021. PMID: 34515837 Free PMC article. Review.

2

The role of nitric oxide in mitochondria. Focus on "Modulation of mitochondrial Ca2+ by nitric oxide in cultured bovine vascular endothelial cells".

Davidson SM, Yellon DM. Davidson SM, et al. Am J Physiol Cell Physiol. 2005 Oct;289(4):C775-7. doi: 10.1152/ajpcell.00277.2005. Am J Physiol Cell Physiol. 2005. PMID: 16157689 Free article. No abstract available.

3

Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection.

Davidson SM, Hausenloy D, Duchen MR, Yellon DM. Davidson SM, et al. Int J Biochem Cell Biol. 2006 Mar;38(3):414-9. doi: 10.1016/j.biocel.2005.09.017. Epub 2005 Oct 21. Int J Biochem Cell Biol. 2006. PMID: 16280253

4

Does hyperglycemia reduce proliferation or increase apoptosis?

Davidson SM, Yellon DM. Davidson SM, et al. Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1486; author reply H1487. doi: 10.1152/ajpheart.00301.2006. Epub 2006 Apr 14. Am J Physiol Heart Circ Physiol. 2006. PMID: 16617134 Free article. No abstract available.

5

Dissecting out the mechanism of cardioprotection by endogenous erthyropoietin using genetic engineering.

Davidson SM, Yellon DM. Davidson SM, et al. Cardiovasc Res. 2006 Aug 1;71(3):408-10. doi: 10.1016/j.cardiores.2006.06.007. Epub 2006 Jun 14. Cardiovasc Res. 2006. PMID: 16822493 No abstract available.

6

Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.

Lim SY, Davidson SM, Hausenloy DJ, Yellon DM. Lim SY, et al. Among authors: davidson sm. Cardiovasc Res. 2007 Aug 1;75(3):530-5. doi: 10.1016/j.cardiores.2007.04.022. Epub 2007 May 4. Cardiovasc Res. 2007. PMID: 17512507 Free PMC article.

7

Necrostatin: a potentially novel cardioprotective agent?

Smith CC, Davidson SM, Lim SY, Simpkin JC, Hothersall JS, Yellon DM. Smith CC, et al. Among authors: davidson sm. Cardiovasc Drugs Ther. 2007 Aug;21(4):227-33. doi: 10.1007/s10557-007-6035-1. Epub 2007 Jul 31. Cardiovasc Drugs Ther. 2007. PMID: 17665295

8

Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.

Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC. Simpkin JC, et al. Among authors: davidson sm. Basic Res Cardiol. 2007 Nov;102(6):518-28. doi: 10.1007/s00395-007-0671-2. Epub 2007 Aug 13. Basic Res Cardiol. 2007. PMID: 17694254

9

Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.

Bhamra GS, Hausenloy DJ, Davidson SM, Carr RD, Paiva M, Wynne AM, Mocanu MM, Yellon DM. Bhamra GS, et al. Among authors: davidson sm. Basic Res Cardiol. 2008 May;103(3):274-84. doi: 10.1007/s00395-007-0691-y. Epub 2007 Dec 13. Basic Res Cardiol. 2008. PMID: 18080084

10

Assessing mitochondrial potential, calcium, and redox state in isolated mammalian cells using confocal microscopy.

Davidson SM, Yellon D, Duchen MR. Davidson SM, et al. Methods Mol Biol. 2007;372:421-30. doi: 10.1007/978-1-59745-365-3_30. Methods Mol Biol. 2007. PMID: 18314743

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters